Patents by Inventor John Todd Schiller

John Todd Schiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 11806406
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: November 7, 2023
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20220387619
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 8, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • TARGETED CANCER THERAPY
    Publication number: 20220313720
    Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.
    Type: Application
    Filed: November 17, 2021
    Publication date: October 6, 2022
    Inventors: Roy Lobb, Paul Rennert, John Todd Schiller
  • TARGETED COMBINATION THERAPY
    Publication number: 20220152217
    Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.
    Type: Application
    Filed: April 11, 2018
    Publication date: May 19, 2022
    Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human Service
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20220088216
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: December 2, 2021
    Publication date: March 24, 2022
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Targeted cancer therapy
    Patent number: 11207339
    Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: December 28, 2021
    Assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Aleta Biotherapeutics Inc.
    Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20210393797
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 23, 2021
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • TARGETED COMBINATION THERAPY
    Publication number: 20210290778
    Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.
    Type: Application
    Filed: April 11, 2018
    Publication date: September 23, 2021
    Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human Service
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 11110181
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: September 7, 2021
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20200188529
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: January 31, 2020
    Publication date: June 18, 2020
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 10588984
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 17, 2020
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20190083647
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: September 26, 2018
    Publication date: March 21, 2019
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Ser.
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • Virus-like particle conjugates for diagnosis and treatment of tumors
    Patent number: 10117947
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: November 6, 2018
    Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
  • TARGETED CANCER THERAPY
    Publication number: 20180311269
    Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Applicants: The United States of America, as represented by the Secretary, Dept. of Health and Human Service, Aleta Biotherapeutics, Inc.
    Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
  • TARGETED CANCER THERAPY
    Publication number: 20180311374
    Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a papillomavirus particle or soluble papillomavirus protein that targets a tumor, and delivering to the subject an immune cell expressing a receptor that binds to a surface antigen of the papillomavirus particle or soluble papillomavirus protein, respectively.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Serv, Aleta Biotherapeutics, Inc.
    Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
  • VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS
    Publication number: 20160228568
    Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 11, 2016
    Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall